-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Bicara Therapeutics Inc. quarterly/annual Depreciation history and growth rate from 2023 to Q1 2025.
- Bicara Therapeutics Inc. Depreciation for the quarter ending March 31, 2025 was $19K, a 46.2% increase year-over-year.
- Bicara Therapeutics Inc. annual Depreciation for 2024 was $56K, a 195% increase from 2023.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)